logo
In This Issue/Research Watch/News In Brief/News from the IASLC Tobacco Control Committee
A Milestone for the Journal of Thoracic Oncology
The MISSION
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
The International Association for the Study of Lung Cancer Lung Cancer Staging Project
Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer
A Prognostic Model to Predict Mortality among Non–Small-Cell Lung Cancer Patients in the U.S. Military Health System
Identifying Targeted Strategies to Improve Smoking Cessation Support for Cancer Patients
Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils
Increasing Physical Activity and Exercise in Lung Cancer
Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas
EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
Mechanisms of Acquired Resistance to AZD9291
Monotherapy Administration of Sorafenib in Patients With Non–Small Cell Lung Cancer (MISSION) Trial
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non–Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy
Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival
Treatment Outcomes in Stage I Lung Cancer
Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma
Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors
Vortex Keratopathy Presumed Secondary to AZD9291
Exogenous Lipoid Pneumonia Mimicking Multifocal Bronchogenic Carcinoma
MET 14 Deletion in Sarcomatoid Non–Small-Cell Lung Cancer Detected by Next-Generation Sequencing and Successfully Treated with a MET Inhibitor
Waxing and Waning of MET Amplification in EGFR-Mutated NSCLC in Response to the Presence and Absence of Erlotinib Selection Pressure
Inclusion of Lymphangitis as a Descriptor in the New TNM Staging of Lung Cancer
Reply to “Inclusion of Lymphangitis as a Descriptor in the New TNM Staging of Lung Cancer
Cryotherapy for Lung Metastases
Reply to Dr. Macbeth Letter
Do We Know What Is in Our Samples?
Successful AZD9291 Therapy Based on Circulating T790M